Diabetes: When To Treat With Insulin and Treatment Goals



Similar documents
Insulin Initiation and Intensification

A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or

Intensive Insulin Therapy in Diabetes Management

10 to 30 minutes ½ to 3 hours 3 to 5 hours minutes 1 to 5 hours 8 hours. 1 to 4 hours

Intensifying Insulin Therapy

Therapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2

CLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies

INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT

Glycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol

INSULINThere are. T y p e 1 T y p e 2. many different insulins for

Diabetes Medications: Insulin Therapy

Insulin: Breaking Barriers Enhancing Therapies. Jerry Meece, RPh, FACA, CDE

Diabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions

Onset Peak Duration Comments

Insulin Therapy. Endocrinologist. H. Delshad M.D. Research Institute For Endocrine Sciences

Britni Hebert, MD PGY-1

Types of insulin and How to Use Them

Insulin T Y P E 1 T Y P E 2

Diabetes and the Elimination of Sliding Scale Insulin. Date: April 30 th Presenter: Derek Sanders, D.Ph.

Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes

DIABETES MEDICATION INSULIN

Guidelines for Education and Training

Diabetes Treatment in a New Era: When to Begin Insulin and How to deliver it.

Diabetes Fundamentals

Insulin/Diabetes Calculations

Insulin: A Practice Update. Department of Nursing Staff Development Elizabeth Borgelt, MS, RN

A new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration

INSULIN INTENSIFICATION: Taking Care to the Next Level

Insulin switch & Algorithms Rotorua GP CME June Kingsley Nirmalaraj FRACP Endocrinologist BOPDHB

INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco


Prior Authorization Guideline

Let s Talk About Meters and Meds. Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014

Kaiser Sunnyside Medical Center Inpatient Pharmacy Manual

Algorithms for Glycemic Management of Type 2 Diabetes

Most patients with T2DM will eventually require insulin therapy. ADA Glycemic Control Targets. What are some of the obstacles?

Intensifying Insulin In Type 2 Diabetes

Insulin: A Powerful Weapon in the Diabetic Arsenal. Diana Cowell, PharmD PGY-1 Pharmacy Resident

at The Valley Hospital (TVH) for Nursing Students/Nursing Instructors 2012

INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?

Insulin therapy in type 2 diabetes When and how? Disclosures. Learning Objectives. None relevant to today s talk

Presented By: Dr. Nadira Husein

Insulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults

Insulin and Diabetes

2010 Partners & Peers for Diabetes Care, Inc.

(30251) Insulin SQ Prandial Carbohydrate

Prior Authorization Guideline

Dr. John Bucheit, Pharm.D., BCACP, CDE Clinical Assistant Professor Mercer University College of Pharmacy

FYI: (Acceptable range for blood glucose usually mg/dl. know your institutions policy.)

Insulin Pens & Improving Patient Adherence

ADJUSTING INSULIN DOSES CONFLICTS OF INTEREST

Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes

How To Treat Diabetes

Insulin onset, peak and duration of action

Everyday Practice: Diabetes Mellitus

Premixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s

Donovan Victorine Pharm.D. BCACP Clinical Pharmacy Specialist Boise VA Medical Center. U-500 Insulin

Insulin Therapy In Type 2 DM. Sources of support. Agenda. Michael Fischer, M.D., M.S. The underuse of insulin Insulin definition and types

Injectable Insulin During Pregnancy

Insulin. Regimens Characteristics / categorization Pharmacokinetics / pharmacodynamics Adverse effects Compatibility Costs

Diabetes Treatments: Options for Insulin Delivery. Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute

Approximate Cost Reference List i for Antihyperglycemic Agents

The basal plus strategy. Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE

Insulin pen start checklist

Managing the Hospitalized Patient on Insulin: Care Transition. Catie Prinzing MSN, APRN, CNS

BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS

Clinical Assistant Professor. Clinical Pharmacy Specialist Wesley Family Medicine Residency Program. Objectives

INJEX Self Study Program Part 1

Resident s Guide to Inpatient Diabetes

Primary Care Type 2 Diabetes Update

Workshop A Tara Kadis

INSULIN ALGORITHM FOR TYPE 2 DIABETES MELLITUS IN CHILDREN 1 AND ADULTS

TYPE 2 DIABETES SEQUENTIAL INSULIN STRATEGIES

UW MEDICINE PATIENT EDUCATION. Using Insulin. Basic facts about insulin and self-injection. What is insulin? How does diabetes affect the body?

Calculating Insulin Dose

Insulin Pens. Basic facts. What is insulin? What are the different types of insulin?

Glycaemic Control in Adults with Type 1 Diabetes

Endocrine Disorders. Diabetes Meds Objectives. Diabetes Type 1 and Type 2. Insulin Dynamics. Insulin is all about timing! Rapid acting insulin O P D

HEALTH SERVICES POLICY & PROCEDURE MANUAL

Chapter 8 Insulin: Types and Activit y

Insulin therapy in various type 1 diabetes patients workshop

INSULIN THERAPY FOR CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES

Comparative cardiovascular morbidity and mortality in patients taking different insulin regimes for type 2 diabetes: A systematic review

Lipodystrophy: Metabolic and Clinical Aspects. Resource Room Slide Series

In-hospital management of diabetes

Optimizing Insulin Therapy. Calculating Insulin to Carbohydrate Ratios and Correction/Sensitivity Factors

NCT sanofi-aventis HOE901_3507. insulin glargine

THE INS AND OUTS OF INSULIN. Mary Beth Wald, RN,BSN,CDE

Add: 2 nd generation sulfonylurea or glinide or Add DPP-4 inhibitor Start or intensify insulin therapy if HbA1c goals not achieved with the above

Chapter 2 Subcutaneous Insulin: A Guide for Dosing Regimens in the Hospital

Abdulaziz Al-Subaie. Anfal Al-Shalwi

TYPE2DIABETES INSULIN TREATMENT 2009 UPDATE ON A HEALTHCARE PROFESSIONAL S GUIDE TO TREATMENT BY J. ROBIN CONWAY, MD.

SUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS

Insulin Dosing. Meranda Maley, 4 th year PharmD Candidate Florida A & M University Preceptor: Kyle Campbell, PharmD. June 7, 2013

Initiating & titrating insulin & switching in General Practice Workshop 1

When and how to start insulin: strategies for success in type 2 diabetes

Fundamentals of Diabetes Care Module 5, Lesson 1

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Guide for Storage of Insulin

Diabetes Management Tube Feeding/Parenteral Nutrition Order Set (Adult)

Transcription:

Diabetes: When To Treat With Insulin and Treatment Goals Lanita. S. White, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor of Pharmacy Practice, UAMS College of Pharmacy

Disclosures I have no affiliation or financial disclosures.

Objectives Define types of insulin and their actions. Determine when insulin should be initiated or when insulin doses should be titrated in patients with type 2 diabetes. Identify goals of therapy and assessment methods once insulin is initiated in patients with type 2 diabetes. Create appropriate insulin regimens based on provided patient cases in patients with type 2 diabetes.

INSULINS

Rapid Acting - lispro (Humalog ) - glulisine (Apidra ) - aspart (Novolog ) Type Onset Peak Effective Duration 5-15 min 30 90 min < 5 hours Short Acting - Regular Insulin (Novolin R / ReliOn R) (Humulin R) Intermediate Acting - neutral protamine hagedorn (NPH) (Novolin N / ReliOn N) (Humulin N) Long Acting - glargine (Lantus ) - detemir (Levemir ) 30 60 min 2 3 hours 5 8 hours 2 4 hours 4 10 hours 10 16 hours 2 4 hours 1 3 hours No peak Relatively flat 20 24 hours 24 hours

Type Onset Peak Insulin NPH/Insulin Regular - Humulin 70/30 - Novolin 70/30 - ReliOn 70/30 Effective Duration 30 min 2 5 hrs. 18 24 hrs Insulin lispro protamine/insulin lispro - Humalog 75/25 Mix - Humalog 50/50 Mix 15 min 0.5 2.5 hours 16 20 hours Insulin aspart protamine/insulin aspart - Novolog 70/30 Mix 10 20 min 1 4 hours Up to 24 hours

Adapted from Hirsch IB. Insulin analogues. N Engl J Med. 2005;352(2):177.

WHAT IS THE GOAL?

GLYCEMIC GOALS Two ways to assess effectiveness and need for regimen change Self monitoring of blood glucose (SMBG) A1c A1c < 7% Preprandial 70 130mg/dL Postprandial < 180mg/dL 1 2 hours after the beginning of the meal Individual patient considerations

American Diabetes Association Dia Care 2014;37:S14-S80 Copyright 2014 American Diabetes Association, Inc.

WHEN TO START INSULIN?

American Diabetes Association Dia Care 2014;37:S14-S80 Diabetes Care January 2014 vol. 37 no. Supplement 1 S14-S80 Copyright 2014 American Diabetes Association, Inc.

Diabetes Care January 2014 vol. 37 no. Supplement 1 S14-S80 Copyright 2014 American Diabetes Association, Inc.

Diabetes Care January 2014 vol. 37 no. Supplement 1 S14-S80 Copyright 2014 American Diabetes Association, Inc.

Diabetes Care January 2014 vol. 37 no. Supplement 1 S14-S80 Copyright 2014 American Diabetes Association, Inc.

HOW DO WE DO IT?

Starting Insulin Add long-acting (basal) insulin first NPH, insulin glargine, insulin detemir Approach # 1 0.1 0.2 units/kg Example: 81kg patient x 0.2 units/kg = 16.2 units 15 units basal insulin at bedtime or before breakfast Approach # 2 Start a fixed bedtime or morning dose of 10 units Example: 10 units basal insulin at bedtime or before breakfast Treat To Target Study

What to do with the oral medications? Metformin KEEP (low risk of hypoglycemia) SFU/Meglitinides consider d/c (risk of hypoglycemia) Thiazolidinediones consider d/c (risk of hypoglycemia/hf) DPP-4 Inhibitors consider continuation Alpha glucosidase inhibitors consider d/c (no added benefit) SGLT 2 consider continuation

Which insulin should I start with? Long acting (Basal) NPH, insulin glargine, insulin detemir Considerations Number of injections Timing of injections Duration of action Cost Mealtime (Bolus) Regular insulin, insulin aspart, lispro or glulisine Add to regimen as needed to reach postprandial goals

PATIENT CASES

Patient Case MW MW is 54 year old AA male diagnosed with diabetes over a year ago, but only now after a random reading exceeds 300 mg/dl at your office visit is he willing to admit that he has uncontrolled diabetes. He has had a previous heart attack and is taking several cardiovascular and hypertensive medications. His physical exam today is normal. He admits to feeling a little tired, recently, and has been getting up at night to urinate at least two to three times per week.

Patient Case MW Last A1c: 10.2% Height: 6 1 Random glucose in office: 358mg/dL SCr: 0.8 mg/dl BP: 128/88 mmhg Weight: 212 lbs (96 kg) BMI: 28 Metformin 1000mg twice daily Foot Exam: normal pulses and sensation Glipizide 10mg twice daily What do we do?

WHAT ARE THE NEXT STEPS FOR MW?

What are the next steps for MW? Review/Set a goal. Discuss insulin initiation. Start long acting insulin. Approach 2: 10 units at bedtime Discontinue glipizide. Continue metformin. Request fasting SMBG daily and records sent to office. Return to clinic in 3 months.

Patient Case MW Date Time Blood Sugar Notes 3/12 7:00 am 346 mg/dl Started insulin 3/13 7:10 am 333 mg/dl 3/14 7:10 am 332mg/dL 3/16 7:06 am 277 mg/dl 3/17 7:49 am 287 mg/dl 3/18 4:15 pm 301 mg/dl Ate out 3/19 8:01 am 266 mg/dl 3/24 8:00 am 278 mg/dl 3/25 7:14 am 280 mg/dl

Dose Titration for Insulin If average fasting glucose for 7 days is: > 180mg/dL increase by 6 units or 20% (whichever is greater) 141 180 mg/dl increase by 4 units or 10% 121 140 mg/dl increase by 2 units or 10 % 91 120 mg/dl No change in dose < 90 mg/dl decrease dose by 4 units or 10% If any hypoglycemia OR average fasting glucose is: 60 70 mg/dl reduce dose by 10% < 60mg/dL reduce dose by 20%

Patient Case MW Date Time Blood Sugar Notes 3/12 7:00 am 346 mg/dl Started insulin 3/13 7:10 am 333 mg/dl 3/14 7:10 am 332mg/dL 3/16 7:06 am 277 mg/dl 3/17 7:49 am 287 mg/dl 3/18 4:15 pm 301 mg/dl Ate out 3/19 8:01 am 266 mg/dl 3/24 8:00 am 278 mg/dl 3/25 7:14 am 280 mg/dl

What are the next steps for MW? Average blood glucose = 277 mg/dl Increase long acting insulin by 6 units or by 20% Increase from 10 units to 16 units at bedtime Continue fasting SMBG daily and return blood sugars to clinic Return to clinic in 5 weeks

Patient Case MW MW returns to clinic. His A1c has fallen to 9.5% with no reports of hypoglycemia. His weight increased by 2.5 lbs and he is currently taking 16 units of basal insulin. On inspection of blood sugar logs, MW has an average fasting blood glucose of 184mg/dL. What are the next steps for MW?

What are the next steps for MW? Average blood glucose = 184 mg/dl Increase long acting insulin by 6 units or by 20% Increase from 16 units to 22 units at bedtime Continue fasting SMBG daily and return blood sugars to clinic May also consider self titration in appropriate patients: Check fasting blood glucose daily Increase long acting insulin dose by 2 units every 3 days until fasting blood sugars are consistently in the target range

A kink in the plan?? Date Time Blood Sugar Notes 6/17 7:00 am 198 mg/dl 6/18 7:10 am 151 mg/dl 6/19 7:10 am 176 mg/dl 6/20 7:06 am 145 mg/dl Lowest blood sugar 6/24 7:49 am 180 mg/dl Faxed blood sugars 6/25 4:15 pm 234 mg/dl Ate out 6/27 8:01 am 179 mg/dl 6/29 8:00 am 205 mg/dl 6/30 7:14 am 156 mg/dl

What are the next steps for MW? Average blood glucose = 180 mg/dl Often blood sugars have no discernable pattern Use of averages helps to determine level of titration Increase long acting insulin by 6 units or by 20% Increase from 16 units to 22 units at bedtime Same plan Continue fasting SMBG daily and return blood sugars to clinic

Patient Case ES ES is 60 year old Caucasian female diagnosed with diabetes over 5 years ago, she has been on metformin and long acting insulin at bedtime for 3 years. Her fasting blood sugars are consistently within the desired ranges. Her blood pressure and cholesterol are well controlled on medication therapy and her physical exam is normal. She is compliant with her medications and expresses excitement at the birth of her first grandson.

Patient Case ES Last A1c: 8.4% Height: 5 5 Random glucose in office: 201 mg/dl SCr: 1.3 mg/dl BP: 118/90 mmhg Weight: 185 lbs (84kg) BMI: 30.8 Metformin 1000mg twice daily Foot Exam: normal pulses and sensation Insulin glargine 40 units at bedtime What do we do?

WHAT ARE THE NEXT STEPS FOR ES?

What are the next steps for ES? Review the goal. Consider adding mealtime insulin. Approach # 1: Add to largest meal of the day Approach # 2: Add to meal based on preprandial and bedtime readings Continue long acting insulin at current dose. Assess metformin continuation. Request changes in SMBG: fasting, pre prandial and bedtime and blood sugar logs sent in to office.

Patient Case ES ES returns to clinic and is currently taking: insulin glargine 40 units at bedtime Insulin aspart 10 units before dinner Metformin 1000mg twice daily Continue to monitor A1c If A1c still not at goal Adjust mealtime insulin until preprandial/bedtime goals reached Add mealtime insulin to another meal if needed

ON THE HORIZON

Inhaled Insulin - Afrezza Dry-powder recombinant human regular insulin Administered via Afrezza inhaler; can be used for 15 days Insulin particles reach the lung and dissolve on contact with rapid absorption into systemic circulation Approved for adults > 18 years old with T1DM or T2DM In T1MD, must be used with long acting insulin Not for use in children, pregnancy, breastfeeding or DKA

Inhaled Insulin - Afrezza Onset: 12 15 minutes Peak: 60 minutes Duration of action: 2.5 3 hours Unopened packs must be refrigerated Once opened, cartridge must be at room temperature for 10 minutes before use

QUESTIONS?